111 related articles for article (PubMed ID: 24625948)
1. Therapy-related acute promyelocytic leukemia following etoposide-based chemotherapy in non-seminomatous germ cell tumor.
Kumar TN; ; Gandhi LV; Raghunadharao D; Sadashivudu G
J Postgrad Med; 2014; 60(1):84-5. PubMed ID: 24625948
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D
N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
[TBL] [Abstract][Full Text] [Related]
4. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
6. Etoposide-related acute promyelocytic leukemia.
Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II.
De Renzo A; Santoro LF; Notaro R; Pane F; Buonaiuto MR; Luciano L; Rotoli B
Am J Hematol; 1999 Apr; 60(4):300-4. PubMed ID: 10203104
[TBL] [Abstract][Full Text] [Related]
8. MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
Tsujioka T; Wada H; Yamamori S; Otsuki T; Suemori S; Kondo T; Nakanishi H; Suetsugu Y; Mikami M; Sugihara T
Int J Hematol; 2003 Dec; 78(5):439-42. PubMed ID: 14704037
[TBL] [Abstract][Full Text] [Related]
9. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
11. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.
Ottone T; Hasan SK; Voso MT; Ledda A; Montefusco E; Fenu S; Pagoni M; Hubmann M; Lunghi M; Platzbecker U; Lo-Coco F
Am J Hematol; 2014 Mar; 89(3):346-7. PubMed ID: 24375429
[No Abstract] [Full Text] [Related]
13. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
15. Platinum compounds and therapy related acute promyelocytic leukemia.
Martin J; Majumdar G
Hematol J; 2002; 3(6):321-3. PubMed ID: 12522457
[TBL] [Abstract][Full Text] [Related]
16. Insights into leukemogenesis from therapy-related leukemia.
Pedersen-Bjergaard J
N Engl J Med; 2005 Apr; 352(15):1591-4. PubMed ID: 15829541
[No Abstract] [Full Text] [Related]
17. Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
Au WY; Ma SK; Chung LP; Chim CS; Kwong YL
Ann Hematol; 2002 Nov; 81(11):659-61. PubMed ID: 12454706
[TBL] [Abstract][Full Text] [Related]
18. Recurrent rhabdomyosarcoma after adjuvant chemotherapy for stage I non-seminomatous germ cell tumor with malignant transformation.
Ushida H; Koizumi S; Katoh K; Okabe H; Okada Y; Okamoto K
Int J Urol; 2013 May; 20(5):544-6. PubMed ID: 23072289
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II.
Pedersen-Bjergaard J
Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010
[No Abstract] [Full Text] [Related]
20. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]